|
1
|
De Giorgi A, Fabbian F, Cappadona R, Tiseo R, Molino C, Misurati E, Gambuti E, Savriè C, Boari B, Raparelli V, Manfredini R. Do Sex-Related Differences of Comorbidity Burden and/or In-Hospital Mortality Exist in Cancer Patients? A Retrospective Study in an Internal Medicine Setting. Life (Basel) 2021; 11:261. [PMID: 33810124 PMCID: PMC8004908 DOI: 10.3390/life11030261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 03/18/2021] [Accepted: 03/19/2021] [Indexed: 11/26/2022] Open
Abstract
Cancer represents important comorbidity, and data on outcomes are usually derived from selected oncologic units. Our aim was to evaluate possible sex-related differences and factors associated with in-hospital mortality (IHM) in a consecutive cohort of elderly patients with cancer admitted to internal medicine. We included all patients admitted to our department with a diagnosis of cancer during 2018. Based on the International Classification of Diseases, 9th Revision, Clinical Modification, demography, comorbidity burden, and diagnostic procedures were evaluated, with IHM as our outcome. We evaluated 955 subjects with cancer (23.9% of total hospital admissions), 42.9% were males, and the mean age was 76.4 ± 11.4 years. Metastatic cancer was diagnosed in 18.2%. The deceased group had a higher modified Elixhauser Index (17.6 ± 7.7 vs. 14 ± 7.3, p < 0.001), prevalence of cachexia (17.9% vs. 7.2%, p < 0.001), and presence of metastasis (27.8% vs. 16.3%, p = 0.001) than survivors. Females had a higher age (77.4 ± 11.4 vs. 75.5 ± 11.4, p = 0.013), and lower comorbidity (10.2 ± 5.9 vs. 12.0 ± 5.6, p < 0.001) than males. IHM was not significantly different among sex groups, but it was independently associated with cachexia and metastasis only in women. Comorbidities are highly prevalent in patients with cancer admitted to the internal medicine setting and are associated with an increased risk of all-cause mortality, especially in female elderly patients with advanced disease.
Collapse
Affiliation(s)
- Alfredo De Giorgi
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Fabio Fabbian
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
- Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy;
| | - Rosaria Cappadona
- Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy;
| | - Ruana Tiseo
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Christian Molino
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Elisa Misurati
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Edoardo Gambuti
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Caterina Savriè
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Benedetta Boari
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
| | - Valeria Raparelli
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy;
| | - Roberto Manfredini
- Clinica Medica Unit, Azienda Ospedaliero-University of Ferrara, 44121 Ferrara, Italy; (A.D.G.); (R.T.); (C.M.); (E.M.); (E.G.); (C.S.); (B.B.)
- Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy;
| |
Collapse
|
|
2
|
De Giorgi A, Di Simone E, Cappadona R, Boari B, Savriè C, López-Soto PJ, Rodríguez-Borrego MA, Gallerani M, Manfredini R, Fabbian F. Validation and Comparison of a Modified Elixhauser Index for Predicting In-Hospital Mortality in Italian Internal Medicine Wards. Risk Manag Healthc Policy 2020; 13:443-451. [PMID: 32547275 PMCID: PMC7246324 DOI: 10.2147/rmhp.s247633] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Accepted: 04/07/2020] [Indexed: 11/23/2022] Open
Abstract
Purpose Burden of comorbidities appears to be related to clinical outcomes in hospitalized patients. Clinical stratification of admitted patients could be obtained calculating a comorbidity score, which represents the simplest way to identify the severity of patients' clinical conditions and a practical approach to assess prevalent comorbidities. Our aim was to validate a modified Elixhauser score for predicting in-hospital mortality (IHM) in internal medicine admissions and to compare it with a different one derived from clinical data previously used in a similar setting, having a good prognostic accuracy. Patients and Methods A single-center retrospective study enrolled all patients admitted to internal medicine department between January and June 2016. A modified Elixhauser score was calculated from chart review and administrative data; moreover, a second prognostic index was calculated from chart review only. Comorbidity scores were compared using c-statistic. Results We analyzed 1614 individuals without selecting the reason for admission, 224 (13.9%) died during hospital stay. Deceased subjects were older (83.3±9.1 vs 78.4±13.5 years; p<0.001) and had higher burden of comorbidities. The modified Elixhauser score calculated by administrative data and by chart review and the comparator one was 18.13±9.36 vs 24.43±11.27 vs 7.63±3.3, respectively, and the c-statistic was 0.758 (95% CI 0.727-0.790), 0.811 (95% CI 0.782-0.840) and 0.740 (95% CI 0.709-0.771), respectively. Conclusion The new modified Elixhauser score showed a similar performance to a previous clinical prognostic index when it was calculated using administrative data; however, its performance improved if calculation was based on chart review.
Collapse
Affiliation(s)
- Alfredo De Giorgi
- Department of Internal Medicine, University Hospital St. Anna, Ferrara, Italy
| | - Emanuele Di Simone
- Department of Internal Medicine, University Hospital St. Anna, Ferrara, Italy
| | - Rosaria Cappadona
- Department of Medical Sciences, Faculty of Medicine, Pharmacy and Prevention, University of Ferrara, Ferrara, Italy
| | - Benedetta Boari
- Department of Internal Medicine, University Hospital St. Anna, Ferrara, Italy
| | - Caterina Savriè
- Department of Internal Medicine, University Hospital St. Anna, Ferrara, Italy
| | - Pablo J López-Soto
- Department of Nursing, Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Córdoba, Córdoba, Spain
| | - María A Rodríguez-Borrego
- Department of Nursing, Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Córdoba, Córdoba, Spain
| | - Massimo Gallerani
- Department of Internal Medicine, University Hospital St. Anna, Ferrara, Italy
| | - Roberto Manfredini
- Department of Medical Sciences, Faculty of Medicine, Pharmacy and Prevention, University of Ferrara, Ferrara, Italy
| | - Fabio Fabbian
- Department of Medical Sciences, Faculty of Medicine, Pharmacy and Prevention, University of Ferrara, Ferrara, Italy
| |
Collapse
|